Nutex Health Inc.
NUTX
$131.90
-$3.58-2.64%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.22% | -41.12% | 239.87% | 220.69% | 213.98% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.22% | -41.12% | 239.87% | 220.69% | 213.98% |
| Cost of Revenue | 34.98% | -10.71% | 107.91% | 132.33% | 66.37% |
| Gross Profit | -21.23% | -62.08% | 494.61% | 380.45% | 760.56% |
| SG&A Expenses | -72.22% | -389.15% | 107.24% | 761.53% | 332.72% |
| Depreciation & Amortization | 7.86% | -1.78% | 0.62% | 15.77% | 21.64% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.12% | -97.38% | 100.03% | 228.03% | 98.67% |
| Operating Income | 0.75% | 29.44% | 1,192.30% | 181.36% | 5,462.83% |
| Income Before Tax | 7.50% | -76.17% | 4,903.84% | 507.89% | 46,952.63% |
| Income Tax Expenses | -32.40% | 1.46% | 491.93% | 748.77% | 5,133.33% |
| Earnings from Continuing Operations | 23.53% | -83.31% | 1,451.00% | 436.35% | 9,473.80% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 46.07% | 87.40% | -2,448.61% | -902.99% | -16,723.03% |
| Net Income | 120.61% | -80.79% | 730.80% | -4,761.81% | 5,928.85% |
| EBIT | 0.75% | 29.44% | 1,192.30% | 181.36% | 5,462.83% |
| EBITDA | 1.17% | 28.06% | 798.87% | 135.88% | 1,421.52% |
| EPS Basic | 78.86% | -85.83% | 580.08% | -3,932.79% | 5,085.22% |
| Normalized Basic EPS | 73.30% | 107.74% | 1,025.07% | -587.07% | 15,297.08% |
| EPS Diluted | 95.90% | -86.16% | 550.35% | -3,932.79% | 4,260.38% |
| Normalized Diluted EPS | 92.09% | 121.00% | 963.70% | -587.07% | 13,425.15% |
| Average Basic Shares Outstanding | 23.34% | 35.59% | 31.40% | 20.63% | 16.87% |
| Average Diluted Shares Outstanding | 11.28% | 27.45% | 40.74% | 20.63% | 33.04% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |